Advocacy intelligence hub — real-time data for patient organizations
Power Life Sciences Inc.
Australia and New Zealand Sarcoma Association
Ascentage Pharma Group Inc. — PHASE1, PHASE2
The Netherlands Cancer Institute
Pfizer — PHASE2
Memorial Sloan Kettering Cancer Center — PHASE2
OHSU Knight Cancer Institute — PHASE1
M.D. Anderson Cancer Center — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Christina L Roland
M.D. Anderson Cancer Center
📍 WESTAMPTON, NJ
Mark Dickson, MD
Memorial Sloan Kettering Cancer Center
George D. Demetri, MD, MD
Dana-Farber Cancer Institute
📍 BOSTON, MA
Hans Gelderblom, Prof
Leiden University Medical Center
Sandra D'Angelo, MD, PhD
Memorial Sloan Kettering Cancer Center
📍 SPRINGFIELD, MO
Elise F Nassif, MD
University of Texas MD Anderson Cancer Center LAO
📍 HOUSTON, TX